Underwriting AgreementQuanterix Corp • November 27th, 2017 • Laboratory analytical instruments • New York
Quanterix Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [·] shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [·] shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 27th, 2017 • Quanterix Corp • Laboratory analytical instruments • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this th day of , 20 , by and between Quanterix Corporation, a Delaware corporation (the “Company”), and (“Indemnitee”).
RESTRICTED STOCK AGREEMENT QUANTERIX CORPORATIONRestricted Stock Agreement • November 27th, 2017 • Quanterix Corp • Laboratory analytical instruments • Delaware
AGREEMENT made as of the [ ] day of [ ], 20[ ] (the “Grant Date”), between Quanterix Corporation (the “Company”), a Delaware corporation having its principal place of business in Lexington, Massachusetts and [ ] (the “Participant”).
